Both in Pharmaceuticals
Erasca vs Mirum Pharmaceuticals
Over the past year ERAS returned +545.5% and MIRM returned +36.6%; their daily moves had a correlation of 0.18.
ERAS +545.5% MIRM +36.6%Growth of $1, one year, split-adjusted
| Metric | ERAS | MIRM |
|---|---|---|
| Price | $14.91 | $96.97 |
| Market cap | $5.21B | $6.30B |
| Today | +1.84% | +11.42% |
| 1 month | +4.3% | +22.4% |
| 6 months | +36.8% | −11.9% |
| Year to date | +300.8% | +22.8% |
| 1 year | +526.5% | +36.9% |
| Revenue growth (YoY) | — | +39.6% |
| Gross margin | — | 81.1% |
| Net margin | — | −22.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 9.4× |
| Net cash | $268.7M | -$357.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.7% | 44.1% |
| Short % of float | 14.5% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).